Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Decision and Details
Post-event disclosure concerning the absorption-type merger with シスメックスメディカ株式会社
Decision21 November 2025 (date of execution of the absorption-type merger agreement)
Period CoveredFrom 1 April 2026 onward
Implementation1 April 2026 (effective date; completed)
Going forwardDate of registration of change: 1 April 2026 (scheduled)
AmountMerger consideration: None; changes in share capital, capital reserve and retained earnings reserve: None
Quantity / scaleAll issued shares of シスメックスメディカ株式会社 (held by the Company), 400 common shares
Reason
Because シスメックスメディカ株式会社 is a wholly owned subsidiary of SYSMEX CORPORATION, no shares or other monetary consideration will be allocated in connection with the merger.
| Item | Details |
|---|---|
| Matter Covered | Post-event disclosure concerning the absorption-type merger with シスメックスメディカ株式会社 |
| Decision Date | 21 November 2025 (date of execution of the absorption-type merger agreement) |
| Implementation Date | 1 April 2026 (effective date; completed) |
| Period Covered | From 1 April 2026 onward |
| Amount | Merger consideration: None; changes in share capital, capital reserve and retained earnings reserve: None |
| Quantity / scale | All issued shares of シスメックスメディカ株式会社 (held by the Company), 400 common shares |
| Reason | Because シスメックスメディカ株式会社 is a wholly owned subsidiary of SYSMEX CORPORATION, no shares or other monetary consideration will be allocated in connection with the merger. |
| Governing Rule | Article 200, Items 2 through 7 of the Ordinance for Enforcement of the Companies Act; Article 785, Paragraph 1, Article 789, Paragraphs 2 and 3, Article 796, Paragraph 2, Article 797, Paragraph 1, and Article 799, Paragraphs 2 and 3 of the Companies Act |
| Future plans | Date of registration of change: 1 April 2026 (scheduled) |
Items this document does not state (3)
Decision-Making BodyImpact on Business PerformanceRelated previous disclosures
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The merger was carried out as a statutory procedure for absorbing a wholly owned subsidiary. The document states that, following the merger, the surviving company’s assets are expected to continue to substantially exceed its liabilities and that the merger is not expected to impede the performance of its obligations.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.